迪嘉药业集团股份有限公司
Dijia Pharmaceutical Group Co. Ltd.
Country: CN CDE+DMF+CEP MEDIUM
🇨🇳 CDE
41
41 products shown
🇺🇸 DMF
1
1 products shown
🇪🇺 CEP
4
4 products shown
Total
46
registrations
🇨🇳 CDE 注册 (41)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Amlodipine 氨氯地平 | 88150-42-9 | Class A | Y20190006715 |
| Apixaban 阿哌沙班 | 503612-47-3 | Class A | Y20210000289 |
| Azelnidipine 阿折地平 | 123524-52-7 | Class A | Y20190001338 |
| Azilsartan Medoxomil 阿齐沙坦 | 863031-21-4 | Class A | Y20210000477 |
| Bupropion 盐酸安非他酮 | 34911-55-2 | Class A | Y20190006714 |
| Candesartan Cilexetil 坎地沙坦酯 | 139481-59-7 | Class A | Y20190001594 |
| Celecoxib 塞来昔布 | 169590-42-5 | Class A | Y20170001274 |
| Dapagliflozin HS-10353 | 461432-26-8 | Class I | Y20240001043 |
| Donepezil 多奈哌齐 | 120014-06-4 | Class A | Y20200000598 |
| Empagliflozin 恩格列净 | 864070-44-0 | Class I | Y20250000619 |
| Eszopiclone 右佐匹克隆 | 138729-47-2 | Class A | Y20190000246 |
| Febuxostat 非布司他 | 144060-53-7 | Class A | Y20200000997 |
| Flavoxate 盐酸黄酮哌酯 | 15301-69-6 | Class A | Y20190006707 |
| Flunarizine 盐酸氟桂利嗪 | 52468-60-7 | Class A | Y20190001607 |
| Fudosteine 福多司坦 | 13189-98-5 | Class A | Y20190006099 |
| Glimepiride 格列美脲 | 93479-97-1 | Class I | Y20240001073 |
| Glipizide 格列吡嗪 | 29094-61-9 | Class A | Y20210000748 |
| Glipizide 格列吡嗪 | 29094-61-9 | Class A | Y20190001588 |
| Gliquidone 格列喹酮 | 33342-05-1 | Class A | Y20190006417 |
| Glucosamine 盐酸氨基葡萄糖 | 3416-24-8 | Class I | Y20250001154 |
| Itopride 盐酸伊托必利 | 122898-67-3 | Class A | Y20240000585 |
| Linagliptin 利格列汀 | 668270-12-0 | Class I | Y20240000494 |
| Loxoprofen Sodium 洛索洛芬钠 | 68767-14-6 | Class A | Y20190007707 |
| Lurasidone 盐酸鲁拉西酮 | 367514-87-2 | Class I | Y20240000230 |
| Methoxyphenamine 盐酸甲氧那明 | 93-30-1 | Class A | Y20220001253 |
| Mirabegron 米拉贝隆 | 223673-61-8 | Class I | Y20250000819 |
| Montelukast Sodium 孟鲁司特钠 | 158966-92-8 | Class A | Y20220000801 |
| Nifedipine 硝苯地平 | 21829-25-4 | Class A | Y20170000113 |
| Olmesartan Medoxomil 奥美沙坦酯 | 144689-63-4 | Class A | Y20170001305 |
| Oxybutynin Hydrochloride 盐酸奥昔布宁 | 5633-20-5 | Class A | Y20190006878 |
| Rivaroxaban 利伐沙班 | 366789-02-8 | Class A | Y20200001430 |
| Sacubitril/valsartan Sodium 沙库巴曲缬沙坦钠 | 137862-53-4 | Class A | Y20200001422 |
| Sildenafil 枸橼酸西地那非 | - | Class A | Y20200001215 |
| Solifenacin 琥珀酸索利那新 | 242478-37-1 | Class A | Y20220000280 |
| Tadalafil 他达拉非 | 171596-29-5 | Class A | Y20200000514 |
| Telmisartan 替米沙坦 | 144701-48-4 | Class A | Y20200001151 |
| Terazosin 盐酸特拉唑嗪 | 63590-64-7 | Class A | Y20190006794 |
| Trelagliptin 琥珀酸曲格列汀 | 1029877-94-8 | Class I | Y20250001422 |
| Urapidil 盐酸乌拉地尔 | 34661-75-1 | Class A | Y20230000187 |
| Vonoprazan 富马酸伏诺拉生 | 881681-00-1 | Class I | Y20240000683 |
| Zopiclone 佐匹克隆 | 43200-80-2 | Class I | Y20250000620 |
🇺🇸 DMF 注册 (1)
| Product | CAS | DMF Number | Date |
|---|---|---|---|
| Glipizide 格列吡嗪 | 29094-61-9 | - | 1994-08-05 |
🇪🇺 CEP 注册 (4)
| Product | CAS | CEP Number | Date |
|---|---|---|---|
| Glipizide 格列吡嗪 | 29094-61-9 | R1-CEP 2012-117 - Rev 02 | - |
| Rivaroxaban 利伐沙班 | 366789-02-8 | CEP 2024-174 - Rev 00 | - |
| Solifenacin Succinate | 242478-38-2 | CEP 2024-479 - Rev 00 | - |
| Terazosin Hydrochloride Dihydrate 特拉唑嗪 盐酸盐 二水合物 | 70024-40-7 | CEP 2022-409 - Rev 00 | - |
Source: cde_raw+map_250k | Updated: 2026-04-09 07:23:01